Heart Rate Variability as Early Biomarker for the Evaluation of Diabetes Mellitus Progress

Figure 1

Characterization of chronic diabetes mellitus model. (a) Distributions of glucose plasma. (b) The plot shows that the cDM-model mice are losing weight since the third week after STZ-injection. (c) Increased plasma glucose. (d) Decreased insulin plasma. (e–h) Nonfasting lipid profile (LDL, HDL, total cholesterol, and triglycerides) is altered for the treatment. = animals number, (<0.05) versus control (dark line), and #: versus first weight (grey line).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)